Business Context and Reporting Period
This Form 10-Q covers the quarterly period ended March 31, 2002, for Croff Enterprises, Inc. (Note: The request metadata listed "Therapeuticsmd, Inc.", but the filing text explicitly identifies the registrant as Croff Enterprises, Inc.). The company operates in the oil and gas sector, utilizing the successful efforts method of accounting. As of May 10, 2002, there were 566,060 shares of common stock outstanding.
Key Financial Metrics
| Metric | Q1 2002 | Q1 2001 |
|---|---|---|
| Total Revenues | $74,238 | $125,387 |
| Oil and Gas Sales | $49,321 | $122,361 |
| Net Income | $22,818 | $39,294 |
| Net Income (Common Shareholders) | $23,475 | $1,411 |
| EPS (Basic & Diluted) | $0.04 | $0.01 |
| Operating Cash Flow | $16,465 | $47,291 |
| Cash and Equivalents (End of Period) | $378,361 | $238,725 |
| Total Assets | $713,227 | $695,124 |
| Working Capital | $415,437 | $385,816 |
| Debt | $0 | $0 |
Liquidity: The company reported a current ratio of approximately 22:1. There is no short-term or long-term debt.
Material Changes vs. Prior Period
- Revenue Decline: Total revenues decreased 41% to $74,238. Oil and gas sales dropped 60% to $49,321 due to lower commodity prices and reduced production volumes.
- Commodity Prices: Average oil sales price fell from $25 (2001) to $17 (2002). Natural gas prices dropped from $5.80/Mcf to $1.80/Mcf.
- Production: Well operators slowed production due to low prices and reduced demand.
- Investment Gains: The company recorded a $23,026 gain on the sale of marketable equity securities, partially offsetting the decline in operating revenue.
- Expense Reduction: Lease operating expenses decreased 70% to $14,014, driven by lower production volumes and associated taxes.
- Profitability: While total net income decreased 42%, net income applicable to common shareholders increased significantly due to a reallocation of preferred stock dividends.
Outlook, Risks, and Management Commentary
- Outlook: Management expects to continue operating at a positive cash flow for the remainder of 2002 and intends to resume purchasing oil and natural gas leases.
- Inflation: The company views inflation as generally favorable because revenues are tied to commodity prices while operating expenses are not significant.
- Risks: Operations are heavily dependent on the commodity prices of oil and natural gas. Forward-looking statements regarding growth and inventory management are subject to change.
- Related Party Transactions: The company holds notes receivable from directors ($40,663) and a related party (Reef Energy Corporation, $15,000 loan).
Investor Verification Checklist
- Verify the significant drop in oil and gas production volumes and the specific impact of commodity price fluctuations on future quarters.
- Confirm the sustainability of the $23,026 gain from marketable securities, as this was a non-recurring item offsetting operating declines.
- Review the status of the $40,066 in notes receivable from directors and the $15,000 loan to Reef Energy Corporation for collectability risks.
- Assess the company's plan to resume purchasing leases given the current low price environment for oil and gas.
- Clarify the discrepancy between the request metadata (Therapeuticsmd, Inc.) and the actual filing registrant (Croff Enterprises, Inc.).